EvodiaBio raised €6.0M in a funding round in Dec 2025. The company is based in Copenhagen, Denmark. Investors in the round: Ananke Ventures, Andreas Fibig, Anne Cabotin and 10 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €6.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.